Prescient Healthcare Group has been recognized, for the third year in a row, as one of the 50 fastest-growing privately owned pharma companies in the UK. Companies in the Alantra Pharma Fast 50 are passionate about the potential of their businesses to deliver lasting...
Prescient’s Dr. Julia Seaman shares her thoughts on monitoring COVID-19 in the American Society for Quality’s March issue of Quality Progress. More data are needed to track the full implications surrounding the coronavirus crisis. Read the full report...
We are excited to officially announce that we will be opening a Boston office! Our new office, Prescient’s sixth, will allow us to place teams on the ground to deliver services side by side with existing clients, as well as build relationships with new clients in the...
Prescient will be in Zurich for the 2020 Pharma CI Europe Conference and Exhibition on March 19-20, 2020. On Thursday, March 19, at 2:55 PM, Prescient will lead a podium session on: Emerging Trends within the Biopharma Industry The evolution of challenges and rising...
Prescient hires two new senior members to support its fast-growing Advisory business LONDON, February 12, 2020—Prescient, a biopharma product and portfolio strategy firm, announces the recent appointment of two new senior members, Kevin Baruzzi and Dr. Arun R....
